Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Other Accumulated Expenses (2021 - 2025)

Medicinova (MNOV) has disclosed Other Accumulated Expenses for 4 consecutive years, with $146540.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $146540.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $146540.0, a N/A change, with the full-year FY2025 number at $146540.0, changed N/A from a year prior.
  • Other Accumulated Expenses was $146540.0 for Q4 2025 at Medicinova, down from $164375.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $547270.0 in Q4 2021 to a low of $146540.0 in Q4 2025.
  • A 3-year average of $286061.7 and a median of $164375.0 in 2023 define the central range for Other Accumulated Expenses.